RIA
TBIO

Realta Investment Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Realta Investment Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,200
Closed -$22K – 1561
2019
Q4 		$22K Hold
2,200
– – 0.01% 905
2019
Q3 		$22K Buy
+2,200
New +$20.8K 0.01% 896

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Realta Investment Advisors's TBIO Position: Q1 2020 in Review

Realta Investment Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q1 2020, closing a stake of 2,200 shares — an estimated $22K sold.

Realta Investment Advisors first reported a position in TBIO in Q3 2019 and held it in 2 quarters. The position peaked at $22K in Q4 2019. 74 funds tracked by Wall St. Rank hold TBIO as of Q1 2020.

  • Realta Investment Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Realta Investment Advisors sold 2,200 Translate Bio, Inc. Common Stock shares in Q1 2020, an estimated $22K.
  • Realta Investment Advisors first reported a position in Translate Bio, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • Realta Investment Advisors's Translate Bio, Inc. Common Stock position peaked at $22K in Q4 2019.
  • 74 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q1 2020.

Based on Realta Investment Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.